LatchBio
LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.
About LatchBio
LatchBio develops a data infrastructure intended to build and disseminate the open-source infrastructure of the biocomputing revolution. Founded in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, the company creates open-source machine learning and cloud infrastructure for the next generation of therapeutic discovery, thereby enabling biotech companies to find therapies faster and save on engineering.
Company Facts
- Headquarters
- San Francisco
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $33,200,000
- Last Funding Type
- series_a
- Last Funding Date
- 2022-06-02
- Website
- latch.bio
Industries & Categories
Artificial Intelligence (AI), Bioinformatics, Biopharma, Biotechnology, Machine Learning
Social Links
Canonical: https://fsome.com/organization/latchbio-75665 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.